Analysis: Case numbers high as vaccines for children approved and booster rollout slows
The amount of no shows for the third jab has increased as it is offered to younger age groups
Vaccines will soon be available to children after the National Immunisation Advisory Committee approved the Pfizer vaccine for 5 to 11 year olds.
Some 480,000 primary school children will be offered a vaccine, with the majority receiving their doses in January.
This comes as cases have risen dramatically in children in the past two weeks.
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Spain pulls Genrui antigen tests after 1,350 Irish complaints over false positives
Company has identified two contaminated batches and issued product recall for both
€348 million in Covid-19 business supports repaid to Revenue
The government announced the resumption and reopening of supports for businesses in December
Vaccine exemption on medical grounds held up by legal and logistical problems
Consideration is being given to a system to facilitate people who can’t be vaccinated for medical reasons
Analysis: At what point could Covid-19 be reasonably compared to a cold or flu?
Covid-19’s levels of fatality far exceed flu, but Omicron’s reduced severity combined with boosters and the arrival of antiviral pills may change that